Approved indications: Diflunisal is FDA-approved for the symptomatic treatment of mild to moderate pain and for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Off-label uses and evidence: It has been studied off label for transthyretin-related familial amyloid polyneuropathy and other transthyretin amyloidoses, where it can stabilize transthyretin and slow neurologic or cardiac progression in some patients, but newer, targeted therapies are generally preferred; any off-label use is typically supervised by specialists.

Efficacy expectations: For acute pain, relief often begins within about 1 hour and can last around 8–12 hours, allowing twice-daily dosing; in chronic osteoarthritis or rheumatoid arthritis, improvement in pain and stiffness usually develops over several days, with maximum benefit over a few weeks.

Comparison to similar drugs: Overall pain relief is comparable to many other traditional NSAIDs (such as ibuprofen or naproxen), but diflunisal tends to have a longer duration of action per dose, which may reduce dosing frequency without clearly reducing class-related risks like stomach irritation or cardiovascular events.

Typical adult and adolescent dosing (age ≥12 years): For mild to moderate pain, a common regimen is 1000 mg by mouth once as an initial dose, then 500 mg every 12 hours as needed, not exceeding 1500 mg per day. For osteoarthritis or rheumatoid arthritis, usual total daily doses are 500 to 1000 mg, given in two divided doses, also with a 1500 mg per day maximum, individualized to symptom control and tolerability.

Pediatric use: Safety and effectiveness below 12 years of age have not been established, and routine use in younger children is not recommended.

How to take: Swallow tablets whole with water; do not split, crush, or chew them. Taking diflunisal with food, milk, or an antacid can help reduce stomach upset, and doses are typically spaced every 8–12 hours at the same times each day.

Special dosing considerations: In older adults and in people with kidney impairment or multiple medical problems, prescribers often start at the lower end of the dose range and monitor kidney function, blood pressure, and for signs of GI bleeding; use is generally avoided in significant advanced renal disease. It should not be used around the time of coronary artery bypass graft (CABG) surgery.

Missed dose: If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose; if it is close to the next scheduled dose, skip the missed dose and resume the regular schedule without doubling up.

Overdose: In suspected overdose, immediate medical evaluation is important; symptoms can include severe nausea or vomiting, stomach pain, drowsiness, confusion, ringing in the ears, shortness of breath, seizures, or signs of bleeding, and management may involve supportive care and measures to limit further absorption.

Common side effects: The most frequent problems are stomach-related (upset stomach, heartburn, nausea, abdominal pain, diarrhea or constipation), headache, dizziness, drowsiness, and sometimes fluid retention or mild swelling of the ankles or feet; these usually appear early in treatment or after a dose increase and are often mild to moderate.

Serious or rare adverse effects (seek immediate care): Warning signs include chest pain, shortness of breath, sudden weakness or trouble speaking (possible heart attack or stroke); black, tarry, or bloody stools, vomiting blood, or severe stomach pain (possible bleeding ulcer); sudden weight gain, swelling, or decreased urination (kidney injury or fluid overload); yellowing of skin or eyes, dark urine, or severe fatigue (liver injury); severe rash, blistering skin, or peeling; or any signs of a severe allergic reaction such as wheezing, face or throat swelling, or trouble breathing.

Warnings and precautions: Like all non-aspirin NSAIDs, diflunisal can increase the risk of serious cardiovascular events (heart attack, stroke), especially with higher doses, longer use, or preexisting heart disease; it also increases the risk of stomach and intestinal bleeding or ulcers, particularly in older adults, people with prior ulcers or GI bleeding, heavy alcohol users, and those taking blood thinners or steroids.

Special populations: Use is generally avoided in late pregnancy because NSAIDs can harm the unborn baby’s kidneys and cause premature closure of the ductus arteriosus; they are also discouraged from about 20 weeks of gestation onward unless specifically directed. Diflunisal passes into breast milk, so breastfeeding while taking it is usually not recommended. It is not recommended in children younger than 12 years, and people with significant kidney disease, advanced liver disease, uncontrolled high blood pressure, heart failure, or a history of severe NSAID allergy require particular caution or alternative therapies.

Relative safety compared with other NSAIDs: Diflunisal shares the major class risks of traditional NSAIDs (cardiovascular and gastrointestinal), and while its longer action allows less frequent dosing, it is not clearly safer overall than other nonselective NSAIDs and still requires careful use at the lowest effective dose for the shortest necessary duration.

Reporting and safety updates: Side effects can be reported to the FDA MedWatch program (1-800-FDA-1088 or online), and up-to-date safety communications about NSAIDs, including diflunisal, are available on the FDA’s website.

Major drug interactions: Diflunisal can increase bleeding risk when combined with anticoagulants (for example warfarin), antiplatelet drugs (such as aspirin, clopidogrel), other NSAIDs, or SSRIs/SNRIs (certain antidepressants). It may raise blood levels and toxicity risk of lithium and some other drugs, and can enhance kidney toxicity with medications like cyclosporine or certain diuretics.

Effects on blood pressure and kidneys: Like other NSAIDs, diflunisal may reduce the effect of ACE inhibitors, ARBs, and diuretics (water pills), making blood pressure harder to control and increasing the risk of kidney injury, especially in people who are dehydrated, have heart failure, preexisting kidney disease, or are older.

Alcohol, OTC medicines, and supplements: Regular alcohol use and smoking increase the risk of stomach bleeding when combined with diflunisal. Many over-the-counter pain relievers (ibuprofen, naproxen, aspirin) and some herbal products that affect clotting (such as ginkgo, high-dose fish oil, garlic supplements) can further increase bleeding risk if taken together.

Conditions requiring caution or avoidance: Use is generally avoided in people with a history of severe NSAID or aspirin allergy (including asthma attacks, hives, or anaphylaxis), active peptic ulcer or recent GI bleeding, severe kidney or liver impairment, uncontrolled high blood pressure, or significant heart failure, and it is contraindicated for pain in the setting of CABG surgery.

Monitoring needs: For patients taking diflunisal regularly, clinicians often monitor blood pressure, kidney function (serum creatinine and related tests), and sometimes liver enzymes and blood counts, especially in older adults or those on other high-risk medications.

Q: How long does it take for diflunisal to start relieving pain?
A: Diflunisal usually begins to ease pain within about an hour of a dose, with peak effect in a few hours, and a single dose can provide relief for 8 to 12 hours.

Q: Can I take diflunisal with ibuprofen, naproxen, or aspirin?
A: It is generally not recommended to combine diflunisal with other NSAIDs or regular aspirin for pain because this raises the risk of stomach bleeding, ulcers, and kidney problems; low-dose aspirin for heart protection is sometimes used together only under careful medical supervision.

Q: Is diflunisal safer than other NSAIDs?
A: Diflunisal has a similar overall risk profile to other traditional NSAIDs, with important risks for stomach bleeding and cardiovascular events, and while its longer action allows less frequent dosing, it is not clearly safer than alternatives.

Q: Can I drink alcohol while taking diflunisal?
A: Alcohol can increase the chance of stomach irritation and bleeding with diflunisal, so many clinicians advise limiting or avoiding alcohol, especially with regular or high-dose use.

Q: What if I have kidney or liver disease and need pain control?
A: People with moderate to severe kidney or liver problems are at higher risk of serious side effects from diflunisal, so lower doses, close monitoring, alternative pain medicines, or avoiding NSAIDs altogether may be recommended depending on the specific situation.

Store diflunisal tablets at room temperature in a tightly closed container, away from excess heat, moisture, and direct light, and do not freeze them.

Keep the medication out of the reach of children and pets, and do not use tablets that are expired, damaged, or no longer needed.

For disposal, use a drug take-back program if available; if none is accessible, mix unused tablets (not crushed) with an unappealing substance in a sealed container before placing them in household trash, unless your pharmacist or local guidelines advise a different method.